Back to search
FDAFDA · Food and drugs·Recall number Z-0676-2019

ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome.

Published January 2, 2019 · Recall initiated: November 30, 2018

Summary

FDA records medical device Class II recall Z-0676-2019, published January 2, 2019 and initiated November 30, 2018. Recalling firm: Tosoh Bioscience Inc; Status: Terminated; Reported quantity: 1085 units; Lot: all lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tosoh Bioscience Inc
Distributor
US Nationwide
Lot
all lots
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome. recalled?

Yes. FDA published recall Z-0676-2019 on January 2, 2019.

What should I do if I have this product?

Voluntary: Firm initiated · Letter